Pamidronate induced anti-proliferative, apoptotic, and anti-migratory effects in hepatocellular carcinoma
- 10 November 2005
- journal article
- research article
- Published by Elsevier in Journal of Hepatology
- Vol. 44 (1) , 142-150
- https://doi.org/10.1016/j.jhep.2005.09.022
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- New insights into the actions of bisphosphonate zoledronic acid in breast cancer cells by dual RhoA-dependent and -independent effectsBritish Journal of Cancer, 2003
- RHO–GTPases and cancerNature Reviews Cancer, 2002
- Blocking Oncogenic Ras Signaling for Cancer TherapyJNCI Journal of the National Cancer Institute, 2001
- Cell motility mediated by rho and rho-associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinomaHepatology, 1999
- Rho GTPases are over-expressed in human tumorsInternational Journal of Cancer, 1999
- Inhibition of cell growth of human hepatoma cell line (HepG2) by a farnesyl protein transferase inhibitor: A preferential suppression of ras farnesylationInternational Journal of Cancer, 1996
- Hepatocellular carcinomaDigestive Diseases and Sciences, 1991
- The ras gene family and human carcinogenesisMutation Research/Reviews in Genetic Toxicology, 1988
- ras GENESAnnual Review of Biochemistry, 1987
- The expression of oncogenes in human developing liver and hepatomasBiochemical and Biophysical Research Communications, 1987